A former
Elsa Reed’s lawsuit, filed Monday, centers on a suite of actively managed target-date funds from Fidelity Management Trust Co., which isn’t named as a defendant.
Reed says these funds, which MedStar uses as the default investment option in its $1.8 billion retirement plan, are more expensive and riskier than a similar suite of passively managed Fidelity funds, which Reed says have performed better during the recent Covid-19 ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
